Skip to content

Clinical trials

Active, not recruiting Phase 2 Carcinoma, Hepatocellular trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Phase: Phase 2 Status: Active, not recruiting Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20141
20152
20171
20183
20194
20204
20216
20222
20238
20244
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting40

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)4
AstraZeneca3
Sun Yat-sen University3
Assistance Publique - Hôpitaux de Paris2
AbbVie1
Academic and Community Cancer Research United1
Asan Medical Center1
Boston Scientific Corporation1
Chang Gung Memorial Hospital1
Coherus Oncology, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular40
Liver Neoplasms8
Carcinoma, Non-Small-Cell Lung5
Carcinoma, Renal Cell5
Melanoma4
Cholangiocarcinoma3
Liver Diseases3
Squamous Cell Carcinoma of Head and Neck3
Uterine Cervical Neoplasms3
Biliary Tract Neoplasms2

Trials

Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.